Selected article for: "partial thromboplastin time and thromboplastin time"
Author: Aggarwal, Mukul; Dass, Jasmita; Mahapatra, Manoranjan
Title: Hemostatic Abnormalities in COVID-19: An Update
  • Cord-id: 4a4vz36h
  • Document date: 2020_8_11
    • ID: 4a4vz36h
    Snippet: COVID-19 has emerged as a pandemic with lung being the primarily afflicted organ. Deranged hemostasis has been observed in patients with COVID-19 with scales tipped towards a prothrombotic state. The pathogenesis differs from disseminated intravascular coagulation with a primary pulmonary localization. This is referred to as pulmonary intravascular coagulopathy with strong component of thrombo-inflammation. This is reflected in the lab tests with an increase in D-dimer which correlates with seve
    Document: COVID-19 has emerged as a pandemic with lung being the primarily afflicted organ. Deranged hemostasis has been observed in patients with COVID-19 with scales tipped towards a prothrombotic state. The pathogenesis differs from disseminated intravascular coagulation with a primary pulmonary localization. This is referred to as pulmonary intravascular coagulopathy with strong component of thrombo-inflammation. This is reflected in the lab tests with an increase in D-dimer which correlates with severity and outcomes of disease. Common coagulation tests such as prothrombin time, activated partial thromboplastin time are only mildly prolonged while most patients have normal to increased fibrinogen and marginal thrombocytopenia. Overall, the patients have an increase in venous and arterial thrombotic events especially in ICU patients. Routine thromboprophylaxis with low molecular weight heparin is recommended in all hospitalized patients to reduce the incidence of thrombosis. Bleeding is uncommon and treated with blood products transfusion. This review shall discuss the hemostatic abnormalities in COVID-19 patients and their impact on prognosis. In addition, strategy of thromboprophylaxis and various academic society guidelines are discussed in detail.

    Search related documents:
    Co phrase search for related documents
    • abnormal pt and acute respiratory: 1
    • academic society and acute respiratory: 1, 2, 3
    • accurate predictor and acute respiratory: 1, 2, 3
    • active bleeding and acute respiratory: 1, 2
    • active bleeding and acutely ill: 1
    • active bleeding and lmwh heparin: 1, 2, 3
    • active bleeding and lmwh intermediate dose: 1
    • acute respiratory and addition progression: 1, 2
    • acute respiratory and additional mechanism: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory and lmwh heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and lmwh intermediate dose: 1, 2
    • acutely ill and addition progression: 1
    • acutely ill and lmwh heparin: 1, 2, 3, 4
    • acutely ill and lmwh intermediate dose: 1, 2